Fundz

Who to call at NLS Pharmaceutics Ltd, and when

Fundz watches for the moments NLS Pharmaceutics Ltd starts buying, and tells you who to reach.

  • An alert the day NLS Pharmaceutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NLS Pharmaceutics Ltd, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchNLS Pharmaceutics Launches Preclinical Program for Mazindol ER to Treat Fentanyl Dependence

Jan 28, 2025
ZurichManufacturingBiotechnologyHealthcareHealth CareTherapeutics

Product Description

NLS Pharmaceutics Ltd. announces the launch of a preclinical program to evaluate Mazindol ER as a potential treatment for fentanyl dependence, addressing an urgent medical need amidst the opioid epidemic.

Company Information

Company

NLS Pharmaceutics Ltd

Location

THE CIRCLE 6

Zurich, Zurich, Switzerland

About

NLS Pharmaceutics is a biopharmaceutical company that specializes in developing innovative therapies for patients with central nervous system disorders. The company's focus includes a diversified pipeline aimed at addressing serious unmet medical needs. It aims to improve the lives of patients through advanced drug delivery systems and small-molecule expertise.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NLS Pharmaceutics Ltd ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Alex hidden

hidden
hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NLS Pharmaceutics Ltd's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

NLS Pharmaceutics Ltd shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.